FDA Approved: BROMOCRIPTINE MESYLATE — Original Application (Padagis US LLC)

View source ↗

Summary

FDA approved Padagis US LLC's original generic application for bromocriptine mesylate. This approval provides a generic version of bromocriptine for indications…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Hyperprolactinemia
• Parkinson Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Bromocriptine mesylate (bromocriptine mesylate)

Snippet

ORIG AP for BROMOCRIPTINE MESYLATE (BROMOCRIPTINE MESYLATE)